Actively Recruiting
Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment
Led by Mario Steffanus · Updated on 2025-05-29
162
Participants Needed
2
Research Sites
34 weeks
Total Duration
On this page
Sponsors
M
Mario Steffanus
Lead Sponsor
D
Dr Cipto Mangunkusumo General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to compare the effects of tegoprazan vs lansoprazole in healing bleeding peptic ulcers. It will also teach about the safety of both modalities. The main questions it aims to answer are: How does the effectiveness of Tegoprazan compare with Lansoprazole in two weeks of healing rate bleeding peptic ulcer patients in the Indonesian population? Researchers will compare the drug tegoprazan to lansoprazole with a double-blind randomized control to see their effect on healing bleeding peptic ulcers. Participants will: Take drug tegoprazan 50 mg OD or lansoprazole 30 mg OD every day for 2 weeks Endoscopic examination at the beginning before treatment and after completion of treatment within 2 weeks Record of their adverse effect occurrence
CONDITIONS
Official Title
Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with upper gastrointestinal bleeding caused by peptic ulcer through gastroscopic examination
You will not qualify if you...
- Allergic to Tegoprazan or Lansoprazole
- Diagnosed with gastric or duodenal cancer
- Pregnant
- History of H. pylori infection treatment failure
- Presence of comorbidities such as chronic kidney disease or decompensated liver cirrhosis
- Alcohol consumption
- Undergoing chemotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Cipto Mangunkusumo National General Hospital
Jakarta, DKI Jakarta, Indonesia, 10430
Actively Recruiting
2
Atma Jaya Hospital
Jakarta, DKI Jakarta, Indonesia, 14440
Actively Recruiting
Research Team
M
Mario Steffanus MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here